Imaging of melanoma: Usefulness of ultrasonography before and after contrast injection for diagnosis and early evaluation of treatment

Clinical, Cosmetic and Investigational Dermatology

Volumn 4, Issue , 2011, Pages 1-6

  Chami, Linda ^a,b   Lassau, Nathalie ^a,b   Chebil, Mohamed ^a   Robert, Caroline ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Dynamic contrast enhanced ultrasound; Melanoma; Ultrasound

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; OMBRABULIN; SHU 508; SONOVUE;

ANTIANGIOGENIC THERAPY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORPHOLOGY; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; DATA ANALYSIS SOFTWARE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DOPPLER ECHOGRAPHY; DRUG TARGETING; EARLY DIAGNOSIS; ECHOGRAPHY; FUNCTIONAL ASSESSMENT; GRAY SCALE ECHOGRAPHY; HISTOMETRY; HISTOPATHOLOGY; HUMAN; IMAGE DISPLAY; IMAGE QUALITY; MELANOMA; METASTASIS; MICROBUBBLE; MICROVASCULATURE; NON INVASIVE PROCEDURE; NONHUMAN; PATIENT MONITORING; PREDICTION; REAL TIME ECHOGRAPHY; SEBORRHEIC KERATOSIS; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; SKIN DEFECT; SKIN STRUCTURE; SKINFOLD THICKNESS; TREATMENT RESPONSE; TUMOR VASCULARIZATION;

EID: 79953144595     PISSN: None     EISSN: 11787015     Source Type: Journal    
DOI: 10.2147/CCID.S13499     Document Type: Article

References (38)

1. Weichenthal M, Mohr P, Breitbart EW. The velocity of ultrasound in human primary melanoma tissue-implications for the clinical use of high resolution sonography. BMC Dermatol. 2001;1:1.
2. Kraus W, Schramm P, Hoede N. First experiences with a high resolution ultrasonic scanner in the diagnosis of malignant melanomas. Arch Dermato Res. 1983;275:235-238.
3. Dines K, Sheets P, Bink J, et al. High-frequency ultrasonic imaging of skin: Experimental results. Ultrason Imaging. 1984;6:408-434.
4. Hoffman K, Jung J, El Gammal S, Altmeyer P. Malignant melanoma in 20-MHz B scan US. Dermatology. 1992;185:49-55.
5. Fornage B, McGavran M, Duvic M, Waldron C. Imaging of the skin with 20 MHz sonography. Radiology. 1993;189:69-79.
6. Harland C, Kale S, Jackson P, Mortimer P, Bamber J. Differentiation of common benign pigmented skin lesions from melanoma by highresolution ultrasound. Br J Dermatol. 2000;143:281-289.
7. Bessoud B, Lassau N, Koscielny S, et al. High-frequency sonography and color Doppler in the management of pigmented skin lesions. Ultrasound Med Biol. 2003;29:875-879.
8. Lassau N, Spatz A, Avril MF, et al. Value of high-frequency US for preoperative assessment of skin tumors. Radiographics. 1997;17: 1559-1565.
9. Harland C, Bamber JC, Gusterson B, Mortimer P. High-frequency, high resolution B-scan ultrasound in the assessment of skin tumours. Br J Dermatol. 1993;128:525-532.
10. Gamblicher T, Moussa G, Bahrenberg K, et al. Preoperative ultrasonic assessment of thin melanocytic skin lesions using a 100-MHz ultrasound transducer: A comparative study. Dermatol Surg. 2007;33: 818-824.
11. Guitera P, Li LX, Crotty K, et al. Melanoma histological Breslow thickness predicted by 75-MHz ultrasonography. Br J Dermatol. 2008;159:364-369.
12. Serrone L, Solivetti F, Thorel M, Eibenschuntz L, Donati P, Catricalà C. High frequency ultyrasound in the preoperative staging of primary melanoma: A statistical analysis. Melanoma Res. 2002;12:287-290.
13. Lassau N, Mercier S, Koscielny S, et al. Prognostic value of highfrequency sonography for the preoperative assessment of melanomas. Am J Roentgenol. 1999;172:457-461.
14. Lassau N, Paturel-Asselin C, Guinebretiere JM, et al. New hemodynamic approach to angiogenesis: Color and pulsed Doppler ultrasonography. Invest Radiol. 1999;34:194-198.
15. Machet L, Belot V, Naouri M, et al. Preoperative measurement of thickness of cutaneous melanoma using high-resolution 20 MHz ultrasound imaging: A monocenter prospective study and systematic review of the literature. Ultrasound Med Biol. 2009;35:1411-1420.
16. Samimi M, Perrinaud A, Naouri M, Maruani E, Vaillant L, Machet L. High-resolution ultrasonography assists the differential diagnosis of blue naevi and cutaneous metastases of melanoma. Br J Dermatol. 2010 Jun 10. [Epub ahead of print].
17. Rallan D, Bush N, Bamber J, Harland C. Quantitative discrimination of pigmented lesions using three-dimensional high-resolution ultrasound reflex transmission imaging. J Invest Dermatol. 2007;127:189-195.
18. Srisvastava A, Hughes L, Woodcock J, Laidler P. Vascularity in cutaneous melanoma detected by Doppler sonography and histology: Correlation with tumor behaviour. Br J Cancer. 1989;59:89-91.
19. Giovagnorio F, Andreoli C, de Cicco ML. Color Doppler sonography of focal lesions of the skin and subcutaneous tissue. J Ultrasound Med. 1999;18:89-93.
20. Lassau N, Koscielny S, Avril MF, et al. Prognostic value of angiogenesis evaluated with high-frequency and color Doppler sonography for preoperative assessment of melanomas. Am J Roentgenol. 2002;178: 1547-1551.
21. Barnhill RL, Levy MA. Regressing thin cutaneous malignant melanomas (,or 1.0 mm) are associated with angiogenesis. Am J Pathol. 1993;143:99-104.
22. Straume O, Akslen LA. Expression of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas. Am J Pathol. 2001;159:223-235.
23. Lassau N, Lamuraglia M, Koscielny S, et al. Prognostic value of angiogenesis evaluated with high-frequency and colour Doppler sonography for preoperative assessment of primary cutaneous melanomas: Correlation with recurrence after a 5-year follow-up period. Cancer Imaging. 2006;25:24-29.
24. Lassau N, Chami L, Péronneau P. Current events about echography in 2006: Position of the ultrasound functional imaging for the early evaluation of targeted therapeutics. Bull Cancer. 2006;93: 1207-1211.
25. Marneros AG. Tumor angiogenesis in melanoma. Hematol Oncol Clin North Am. 2009;23:431-446.
26. Perez DG, Suman VJ, Fitch TR, et al. Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: A North Central Cancer Treatment Group study, N047A. Cancer. 2009;115:119-127.
27. Asselin-Paturel C, Lassau N, Guinebretière JM, et al. Transfer of the murine interleukin-12 gene in vivo by the Semliki forest virus induces B16 tumour regression through inhibition of tumour blood vessel formation monitored by Doppler ultrasonography. Gene Ther. 1999; 4:606-615.
28. Kaliski A, Maggiorella L, Rouffiac V, et al. Angiogenic and tumor growth inhibition by an MMP-inhibitor targeting radio-induced MMP-2 and VEGF. Mol Cancer Ther. 2005;11:1717-1728.
29. Escudier B, Lassau N, Couanet D, et al. Phase II trial of thalidomide in renal-cell carcinoma. Ann Oncol. 2002;13:1029-1035.
30. Hochedez P, Lassau N, Bonvalet S, Bidault S, Leclere J, Avril MF. Treatment of local recurrent melanomas by isolated limb perfusion: Value of Doppler ultrasonography. J Radiol. 2003;84:597-603.
31. Grünhagen DJ, van Etten B, Brunstein F, et al. Efficacy of repeat isolated limb perfusion with tumor necrosis factor and mephalan for multiple in-transit metastases in patients with prior isolated limb perfusion failure. Ann Surg Oncol. 2005;12:609-615.
32. Lassau N, Chebil M, Chami L, Bidault S, Girard E, Roche A. Dynamic contrast-enhanced ultrasonography (DCE-US): A new tool for the early evaluation of antiangiogenic treatment. Target Oncol. 2010;5:53-58.
33. Lassau N, Koscielny S, Opolon P, et al. Evaluation of contrast-enhanced color Doppler ultrasound for the quantification of angiogenesis in vivo. Invest Radiol. 2001;36:50-55.
34. Lassau N, Lamuraglia M, Vanel D, et al. Doppler US with perfusion software and contrast medium injection in the early evaluation of isolated limb perfusion of limb sarcomas: Prospective study of 49 cases. Ann Oncol. 2005;16:1054-1060.
35. Eggermont AM. Evolving imaging technology: Contrast-enhanced Doppler ultrasound is early and rapid predictor of tumour response. Ann Oncol. 2005;16:995-996.
36. Brule A, Lassau N, Perronneau P. Intérêt des données linéaires ultrasonores comparées aux données vidéo dans l'étude de la perfusion tumorale. JFR. 2006;87:1381.
37. Lavisse S, Lejeune P, Rouffiac V, et al. Early quantitative evaluation of tumor vasculature disruptive agent AVE8062 using dynamic contrastenhanced ultrasonography. Invest Radiol. 2008;43:100-111.
38. Chami L, Cavalcanti A, Benatsou B, Koscielny S, Chebil M, Lassau N. Dynamic contrast-enhanced ultrasound (DCE-US) and melanoma: Early evaluation of response after isolated limb perfusion (ILP). [Abstract]. RSNA SSK11-08. 2008:533.